The importance of no-reflow/microvascular obstruction in the STEMI patient

Delayed therapeutic hypothermia protects against the myocardial no-reflow phenomenon independently of myocardial infarct size in a rat ischemia/reperfusion model

(2017) Wangde Dai et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Management of No-Reflow Phenomenon in the Catheterization Laboratory

(2017) Shereif H. Rezkalla et al.   JACC-Cardiovascular Interventions

Remote Ischemic Conditioning for Patients With STEMI

(2017) Michael Rahbek Schmidt et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

Dabigatran treatment: effects on infarct size and the no-reflow phenomenon in a model of acute myocardial ischemia/reperfusion

(2014) Sharon L. Hale et al.   JOURNAL OF THROMBOSIS AND THROMBOLYSIS

Door-to-Balloon Time and Mortality among Patients Undergoing Primary PCI

(2013) Daniel S. Menees et al.   NEW ENGLAND JOURNAL OF MEDICINE

No-Reflow Phenomenon: Maintaining Vascular Integrity

(2011) Robert A. Kloner   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS

5-Year Prognostic Value of No-Reflow Phenomenon After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

(2010) Gjin Ndrepepa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Myocardial No-Reflow in Humans

(2009) Giampaolo Niccoli et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

The Extent of Microvascular Damage During Myocardial Contrast Echocardiography Is Superior to Other Known Indexes of Post-Infarct Reperfusion in Predicting Left Ventricular Remodeling

(2008) Leonarda Galiuto et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY